APP Involvement in Monitoring ARIA in Alzheimer Disease

EP: 1.Burden of Alzheimer Disease and Key Stakeholders Involved in Care

EP: 2.Role of APPs in Alzheimer Disease Care in Community and Academic Settings

EP: 3.Strategies for Early Detection in Alzheimer Disease

EP: 4.Impact of Timely Alzheimer Diagnosis on Treatment Selection and Disease Progression

EP: 5.Operational Challenges With Early Identification in Alzheimer Disease

EP: 6.Opportunities for APPs to Lead Early Alzheimer Disease Care

EP: 7.Treatment Options in Alzheimer Disease

EP: 8.Strategies for Identifying Eligible Candidates for Anti-Amyloid Therapies

EP: 9.Role of APPs in the Delivery of Anti-Amyloid Therapies

EP: 10.Navigating Alzheimer Disease Treatment Decisions and Timelines

Now Viewing

EP: 11.APP Involvement in Monitoring ARIA in Alzheimer Disease

EP: 12.Role of APPs in Shared Decision-Making in Alzheimer Disease

Panelists discuss how advanced practice providers (APPs) play a central role in identifying and managing amyloid-related imaging abnormalities (ARIA) that can occur with anti-amyloid therapy. Close monitoring through MRI and patient education are emphasized as best practices.

Panelists discuss how structured protocols help detect ARIA early and ensure prompt clinical response. APPs interpret results, communicate with supervising physicians, and adjust therapy as needed to maintain patient safety.

Panelists discuss how their vigilance and accessibility to patients enhance adherence and confidence in therapy, reinforcing the collaborative nature of Alzheimer care.